Does early rhythm-control therapy reduce adverse cardiovascular outcomes in patients with early atrial fibrillation and cardiovascular conditions?
Early rhythm-control therapy is associated with improved cardiovascular outcomes compared to usual care in patients with early atrial fibrillation.
Early rhythm-control therapy was associated with a lower risk of adverse cardiovascular outcomes than usual care among patients with early atrial fibrillation and cardiovascular conditions. (Funded by the German Ministry of Education and Research and others; EAST-AFNET 4 ISRCTN number, ISRCTN04708680; ClinicalTrials.gov number, NCT01288352; EudraCT number, 2010-021258-20.).
Kirchhof et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: